• Company
• RSV vaccine market for children is expected to be big
• by Hwang, Byung-woo Aug 8, 2024 09:24am

• Company
• Celltrion presents clinical results of Prolia biosimilar
• by Hwang, Byung-woo Aug 8, 2024 09:24am

• Company
• Qalsody receives orphan drug designation in Korea
• by Eo, Yun-Ho Aug 8, 2024 09:24am

• Opinion
• [Reporter's View] govt's foreign drug price comparisons
• by Kim, Jin-Gu Aug 8, 2024 09:24am

• Policy
• Price-Volume Agreement negotiations to be finalized soon
• by Lee, Tak-Sun Aug 8, 2024 09:24am

• Company
• Vaxneuvance increases presence in NIP mkt
• by Hwang, Byung-woo Aug 8, 2024 09:24am

• Company
• Electronic drugs show potential to conquering Alzheimer's
• by Son, Hyung-Min Aug 8, 2024 09:24am

• Company
• Tepezza receives orphan drug designation in Korea
• by Eo, Yun-Ho Aug 6, 2024 09:16am

• Company
• Lily Korea appoints John Bickel as new General Manager
• by Hwang, Byung-woo Aug 6, 2024 09:16am

• Company
• Trials start for 'cancer vaccine+immunooncology drug’ combo
• by Son, Hyung-Min Aug 6, 2024 09:16am